CPQC-ShenYang Station Successfully Completed RT6 12 Positions Automated Dissolution Tester Empowers Northeast Pharmaceutical Enterprises to Upgrade

With the release of the 2025 edition of the Chinese Pharmacopoeia, China’s drug quality management system will be fully aligned with the European and American Pharmacopoeia standards, which puts forward new requirements for enterprise development, quality management, technical capabilities, inspection and control concepts, etc. The 2025 Pharmaceutical Quality Control Technology Conference (CPQC-Shenyang Station) was held on May 22nd at the Longemont Metropark Hotel in Shenyang. As a professional provider of pharmaceutical dissolution meter and dissolution solution, Raytor Instruments was invited to participate in this event, which is of great significance to the development and innovation of pharmaceutical industry.

Raytor team demonstrated the Raytor RT6 12 Positions Automated Dissolution Tester, which is fully compliant with the requirements of Chinese Pharmacopoeia, U.S. Pharmacopoeia, European Pharmacopoeia and other national pharmacopoeias, in Booth No. 14.

In-vitro release and in-vitro permeation tests are of great significance in the performance evaluation, quality evaluation and safety assessment of semi-solid preparations, etc. RT800 Franz Diffusion Cell System can fully satisfy the customer’s expectations of high efficiency and stability of the equipment, reliable results, and diversified test requirements.

Raytor  Instruments will always adhere to the mission of “Make scientific experiments easier”, escorting the quality of drugs with accurate and efficient technology, and looking forward to drawing the blueprint for development with industry partners on more professional platforms!